FDA greenlights Astellas' therapy for menopause-related symp

The FDA based its approval on the results of three Phase III trials where Astellas’ drug showed efficacy and safety in treating moderate to severe VMS.

Related Keywords

Japan , Japanese , Iveric Bio , Carmella Riley , Astellas Pharma , Drug Administration , National Institutes Of Health , National Institutes , Marci English , Super Bowl , New Jersey Based ,